$SBOT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Edesa Biotech, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Edesa Biotech, Inc.. Get notifications about new insider transactions in Edesa Biotech, Inc. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 5.45 | 80,000 | 436,000 | 80,000 | |
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 5.45 | 120,000 | 654,000 | 120,000 | |
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 5.45 | 80,000 | 436,000 | 80,000 | |
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Apr 26 2021 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Option Exercise | A | 5.45 | 20,000 | 109,000 | 20,000 | ||
| Mar 26 2021 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 5.25 | 3,000 | 15,750 | 545,312 | 542.3 K to 545.3 K (+0.55 %) |
| Mar 26 2021 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Buy | P | 5.19 | 3,500 | 18,165 | 13,241 | 9.7 K to 13.2 K (+35.93 %) |
| Mar 25 2021 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 5.16 | 5,000 | 25,800 | 542,312 | 537.3 K to 542.3 K (+0.93 %) |
| Feb 18 2021 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Sell | S | 7.25 | 6,165 | 44,696 | 0 | 6.2 K to 0 (-100.00 %) | |
| Feb 18 2021 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Sell | S | 7.25 | 1,827 | 13,246 | 0 | 1.8 K to 0 (-100.00 %) | |
| Nov 10 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | X | 4.00 | 1,218 | 4,872 | 0 | ||
| Nov 10 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Buy | X | 4.00 | 1,218 | 4,872 | 3,654 | 2.4 K to 3.7 K (+50.00 %) | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | X | 4.00 | 4,262 | 17,048 | 0 | ||
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Buy | X | 4.00 | 4,262 | 17,048 | 12,786 | 8.5 K to 12.8 K (+50.00 %) | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | X | 4.00 | 914 | 3,656 | 0 | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Buy | X | 4.00 | 914 | 3,656 | 5,241 | 4.3 K to 5.2 K (+21.12 %) |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | X | 4.00 | 609 | 2,436 | 0 | |
| Nov 09 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Buy | X | 4.00 | 609 | 2,436 | 1,827 | 1.2 K to 1.8 K (+50.00 %) |
| Nov 06 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | X | 4.00 | 1,218 | 4,872 | 0 | ||
| Nov 06 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Buy | X | 4.00 | 1,218 | 4,872 | 3,654 | 2.4 K to 3.7 K (+50.00 %) | |
| Nov 06 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | X | 4.00 | 4,628 | 18,512 | 0 | |
| Nov 06 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | X | 4.00 | 4,628 | 18,512 | 2,128,652 | 2.1 M to 2.1 M (+0.22 %) |
| Nov 03 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | X | 4.00 | 609 | 2,436 | 0 | ||
| Nov 03 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Buy | X | 4.00 | 609 | 2,436 | 1,827 | 1.2 K to 1.8 K (+50.00 %) | |
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 7.44 | 50,000 | 372,000 | 50,000 | |
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 7.44 | 60,000 | 446,400 | 60,000 | |
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 7.44 | 50,000 | 372,000 | 50,000 | |
| Oct 14 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | A | 7.44 | 20,000 | 148,800 | 20,000 | ||
| Sep 18 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | J | 0.00 | 371,727 | 0 | 371,727 | 0 to 371.7 K |
| May 29 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Buy | P | 3.00 | 1,000 | 3,000 | 4,327 | 3.3 K to 4.3 K (+30.06 %) |
| May 29 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Buy | P | 3.00 | 1,500 | 4,499 | 3,327 | 1.8 K to 3.3 K (+82.10 %) |
| May 28 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 2.98 | 3,000 | 8,939 | 2,124,024 | 2.1 M to 2.1 M (+0.14 %) |
| Mar 19 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 1.90 | 1,000 | 1,898 | 2,121,024 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 19 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 1.83 | 1,000 | 1,828 | 2,120,024 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 19 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 1.90 | 1,000 | 1,898 | 2,119,024 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 19 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 1.86 | 1,000 | 1,860 | 2,118,024 | 2.1 M to 2.1 M (+0.05 %) |
| Mar 19 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Buy | P | 1.89 | 1,000 | 1,890 | 2,117,024 | 2.1 M to 2.1 M (+0.05 %) |
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 3.16 | 68,988 | 218,002 | 68,988 | |
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 3.16 | 88,699 | 280,289 | 88,699 | |
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Feb 14 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | A | 3.16 | 11,389 | 35,989 | 11,389 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 4.00 | 4,628 | 18,512 | 4,628 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 4.80 | 6,942 | 33,322 | 6,942 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 4.11 | 9,255 | 38,038 | 2,116,024 | 2.1 M to 2.1 M (+0.44 %) |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 4.00 | 609 | 2,436 | 609 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Option Exercise | A | 4.80 | 914 | 4,387 | 914 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Grant | A | 4.11 | 1,218 | 5,006 | 1,218 | 0 to 1.2 K | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.00 | 609 | 2,436 | 609 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 4.80 | 914 | 4,387 | 914 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | NIFFENEGGER KATHI | Chief Financial Off ... | Grant | A | 4.11 | 1,218 | 5,006 | 1,218 | 0 to 1.2 K |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | A | 4.00 | 1,218 | 4,872 | 1,218 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Option Exercise | A | 4.80 | 1,827 | 8,770 | 1,827 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Grant | A | 4.11 | 2,436 | 10,012 | 2,436 | 0 to 2.4 K | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | P | 4.00 | 5,952 | 23,808 | 5,952 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | P | 4.00 | 64,362 | 257,448 | 64,362 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | P | 4.80 | 8,928 | 42,854 | 8,928 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Option Exercise | P | 4.80 | 96,542 | 463,402 | 96,542 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Buy | P | 3.20 | 11,903 | 38,090 | 169,502 | 157.6 K to 169.5 K (+7.55 %) | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Buy | P | 3.20 | 128,722 | 411,910 | 1,833,066 | 1.7 M to 1.8 M (+7.55 %) | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | P | 4.00 | 1,218 | 4,872 | 1,218 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Option Exercise | P | 4.80 | 1,827 | 8,770 | 1,827 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Sistilli Carlo | Buy | P | 4.11 | 2,436 | 10,012 | 2,436 | 0 to 2.4 K | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | P | 4.00 | 4,262 | 17,048 | 4,262 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Option Exercise | P | 4.80 | 6,393 | 30,686 | 6,393 | ||
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | JOHNSON LORIN K | Buy | P | 4.11 | 8,524 | 35,034 | 8,524 | 0 to 8.5 K | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | P | 4.00 | 914 | 3,656 | 914 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | P | 4.80 | 1,371 | 6,581 | 1,371 | |
| Jan 10 2020 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Buy | P | 4.11 | 1,827 | 7,509 | 1,827 | 0 to 1.8 K |
| Sep 13 2019 | SBOT | Edesa Biotech, Inc ... | OAKES FRANK R. | Sell | S | 5.72 | 1,809 | 10,345 | 6,165 | 8 K to 6.2 K (-22.69 %) | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 8,600 | 0 | 157,599 | 149 K to 157.6 K (+5.77 %) |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 93,006 | 0 | 1,704,344 | 1.6 M to 1.7 M (+5.77 %) |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 2.16 | 91 | 197 | 1,620 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 2.16 | 2,667 | 5,761 | 47,490 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 12,588 | 0 | 224,094 | 211.5 K to 224.1 K (+5.95 %) |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 118,345 | 0 | 2,106,769 | 2 M to 2.1 M (+5.95 %) |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 30,183 | 0 | 537,312 | 507.1 K to 537.3 K (+5.95 %) |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 2.16 | 91 | 197 | 1,620 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 2.16 | 1,365 | 2,948 | 24,299 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 2.16 | 7,663 | 16,552 | 136,416 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Director | Option Exercise | A | 2.16 | 1,820 | 3,931 | 32,399 | |
| Jul 30 2019 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Director | Grant | A | 0.00 | 786 | 0 | 14,369 | 13.6 K to 14.4 K (+5.79 %) |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 0.38 | 1,529 | 581 | 1,529 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 0.38 | 22,934 | 8,715 | 22,934 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Brooks Michael J | President | Option Exercise | A | 0.38 | 128,753 | 48,926 | 128,753 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Pay Paul William | Director | Option Exercise | A | 0.38 | 30,579 | 11,620 | 30,579 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 0.38 | 1,529 | 581 | 1,529 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 0.38 | 1,529 | 581 | 1,529 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 0.38 | 44,823 | 17,033 | 44,823 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Option Exercise | A | 0.38 | 44,823 | 17,033 | 44,823 | |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 211,506 | 0 | 211,506 | 0 to 211.5 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 211,506 | 0 | 211,506 | 0 to 211.5 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 1,988,424 | 0 | 1,988,424 | 0 to 2 M |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 1,988,424 | 0 | 1,988,424 | 0 to 2 M |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 507,129 | 0 | 507,129 | 0 to 507.1 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | Nijhawan Pardeep | Chief Executive Off ... | Grant | A | 0.00 | 507,129 | 0 | 507,129 | 0 to 507.1 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 148,999 | 0 | 148,999 | 0 to 149 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 148,999 | 0 | 148,999 | 0 to 149 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 1,611,338 | 0 | 1,611,338 | 0 to 1.6 M |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | van der Velden Peter | Director | Grant | A | 0.00 | 1,611,338 | 0 | 1,611,338 | 0 to 1.6 M |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Director | Grant | A | 0.00 | 13,583 | 0 | 13,583 | 0 to 13.6 K |
| Jun 11 2019 | SBOT | Edesa Biotech, Inc ... | MacDonald Sean Arthur | Director | Grant | A | 0.00 | 13,583 | 0 | 13,583 | 0 to 13.6 K |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | Che Tessie M | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | Chun Paul | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | SAMPAT MAYANK D. | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | Aghib Deborah F. | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | HILL DAVID LOUIS | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 13 2019 | SBOT | Stellar Biotechnol ... | Olson Charles V | Director | Option Exercise | A | 1.25 | 357 | 446 | 357 | |
| Mar 11 2019 | SBOT | Stellar Biotechnol ... | OAKES FRANK R. | President & CEO | Sell | S | 1.25 | 4,000 | 5,000 | 47,924 | 51.9 K to 47.9 K (-7.70 %) |
| Oct 12 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Sell | S | 1.31 | 7,047 | 9,260 | 20,741 | 27.8 K to 20.7 K (-25.36 %) | |
| Oct 12 2018 | SBOT | Stellar Biotechnol ... | OAKES FRANK R. | President & CEO | Sell | S | 1.31 | 3,000 | 3,930 | 51,924 | 54.9 K to 51.9 K (-5.46 %) |
| Oct 12 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Sell | S | 1.31 | 7,047 | 9,260 | 20,741 | 27.8 K to 20.7 K (-25.36 %) | |
| Oct 12 2018 | SBOT | Stellar Biotechnol ... | OAKES FRANK R. | President & CEO | Sell | S | 1.31 | 3,000 | 3,930 | 51,924 | 54.9 K to 51.9 K (-5.46 %) |
| Apr 03 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.81 | 4,366 | 3,515 | 0 | 4.4 K to 0 (-100.00 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.80 | 3,500 | 2,790 | 4,366 | 7.9 K to 4.4 K (-44.50 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.81 | 7,000 | 5,635 | 7,866 | 14.9 K to 7.9 K (-47.09 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.79 | 7,000 | 5,530 | 14,866 | 21.9 K to 14.9 K (-32.01 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.79 | 7,000 | 5,530 | 21,866 | 28.9 K to 21.9 K (-24.25 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Sell | S | 0.78 | 7,800 | 6,115 | 28,866 | 36.7 K to 28.9 K (-21.27 %) |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | Che Tessie M | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | Aghib Deborah F. | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | Chun Paul | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | HILL DAVID LOUIS | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | Olson Charles V | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | SAMPAT MAYANK D. | Director | Option Exercise | A | 0.84 | 2,500 | 2,100 | 2,500 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | OAKES FRANK R. | President & CEO | Option Exercise | A | 0.84 | 40,000 | 33,600 | 40,000 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | NIFFENEGGER KATHI | Chief Financial Off ... | Option Exercise | A | 0.84 | 35,000 | 29,400 | 35,000 | |
| Mar 14 2018 | SBOT | Stellar Biotechnol ... | BAXTER GREGORY T. | EVP, Corporate Deve ... | Option Exercise | A | 0.84 | 30,000 | 25,200 | 30,000 | |
| Jan 25 2018 | SBOT | Stellar Biotechnol ... | Aghib Deborah F. | Director | Option Exercise | A | 0.93 | 2,500 | 2,325 | 2,500 | |
| Jun 28 2017 | SBOT | Stellar Biotechnol ... | OAKES FRANK R. | President & CEO | Grant | A | 0.00 | 235,690 | 0 | 384,467 | 148.8 K to 384.5 K (+158.42 %) |
| Jun 28 2017 | SBOT | Stellar Biotechnol ... | MORSE DANIEL E. | Director | Grant | A | 0.00 | 134,680 | 0 | 231,189 | 96.5 K to 231.2 K (+139.55 %) |
| Mar 29 2017 | SBOT | Stellar Biotechnol ... | BAXTER GREGORY T. | EVP, Corporate Deve ... | Option Exercise | A | 1.60 | 10,000 | 16,000 | 10,000 | |
| Mar 27 2017 | SBOT | Stellar Biotechnol ... | SAMPAT MAYANK D. | Director | Option Exercise | A | 1.67 | 2,500 | 4,175 | 2,500 | |
| Mar 27 2017 | SBOT | Stellar Biotechnol ... | Olson Charles V | Director | Option Exercise | A | 1.67 | 2,500 | 4,175 | 2,500 |